首页> 外文OA文献 >Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations

【2h】

Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations

机译：免疫组织化学标志物在中国晚期肺腺癌患者患者EGFR-TKI治疗中的预后意义EGFR突变

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yan Li; Ruiguang Zhang; Xiu Nie; Xiaorong Dong; Gang Wu;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations [J] . Ruiguang Zhang, Yan Li, Xiu Nie, OncoTargets and therapy . 2016,第1期

机译：免疫组化标记物对中国EGFR突变晚期肺腺癌患者EGFR-TKI治疗的预后意义
2. Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy [J] . Li Haixia, Wang Chenyu, Wang Ziqi, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2019,第期

机译：高级肺腺癌患者的疗效和长期存活罕见的EGFR-TKIs治疗，与化疗为一线治疗
3. Clinical efficacy of EGFR-TKIs in combination with chemotherapy in patients with advanced non-small cell lung cancer harboring EGFR mutations [J] . Minghui Zhang, Mingyang Liu, Yan Wang Journal of Thoracic Disease . 2016,第10期

机译：EGFR-TKI与患有EGFR突变的晚期非小细胞肺癌患者化疗组合的临床疗效
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Design, Construction, and Verification of a LATE-PCR and Lights-On/Lights-Off Probe Assay for Mutation Detection in Exons 18-21 of the EGFR Gene: Implications for Molecular Diagnosis of Non-Small Cell Lung Carcinoma [D] . Tetrault, Shana Augustin 2012

机译：用于EGFR基因外显子18-21突变检测的LATE-PCR和开/关灯探针检测的设计，构建和验证：对非小细胞肺癌的分子诊断意义
6. Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations [O] . Ruiguang Zhang, Yan Li, Xiu Nie, 2016

机译：免疫组化标记物对中国EGFR突变晚期肺腺癌患者EGFR-TKI治疗的预后意义
7. Efficacy and Safety of First-Generation EGFR-TKIs Combined with Chemotherapy for Treatment-Naïve Advanced Non-Small-Cell Lung Cancer Patients Harboring Sensitive EGFR Mutations: A Single-Center, Open-Label, Single-Arm, Phase II Clinical Trial [O] . Jinghui Lin, Meifang Li, Shijie Chen, 2021

机译：第一代EGFR-TKI的疗效和安全性联合化疗治疗治疗 - 幼稚高级非小细胞肺癌患者，涉及敏感EGFR突变：单中心，开放标签，单臂，II期临床试验

Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations

著录项

引文网络

相似文献

相关主题

期刊订阅